| Literature DB >> 25002996 |
Henrik H Kralund1, Lilian Ousager2, Nicolaas G Jaspers3, Anja Raams3, Erling B Pedersen4, Else Gade5, Anette Bygum1.
Abstract
Xeroderma Pigmentosum (XP), Trichothiodystrophy (TTD) and Cockayne Syndrome (CS) are rare, recessive disorders caused by mutational defects in the Nucleotide Excision Repair (NER) pathway and/or disruption of basic cellular DNA transcription. To date, a multitude of mutations in the XPD/ERCC2 gene have been described, many of which give rise to NER- and DNA transcription related diseases, which share certain diagnostic features and few overlap patients have been described. Despite increasing understanding of the roles of XPD/ERCC2 in mammalian cells, there is still weak predictability of somatic outcome from many of these mutations. We demonstrate a patient, believed to represent an overlap between XP and TTD/CS. In addition to other organ dysfunctions, the young man presented with Photosensitivity, Ichthyosis, Brittle hair, Impaired physical and mental development, Decreased fertility and Short stature (PIBIDS) suggestive of TTD, but lacking the almost patognomonic "tiger tail" banding of the hair under polarized light. Additionally, he developed basal cell carcinoma aged 28, as well as adult onset kidney failure, features normally not associated with TTD but rather XP/CS. His freckled appearance also suggested XP, but fibroblast cultures only demonstrated x2 UV-sensitivity with expected NER and TFIIH-activity decrease. Genetic sequencing of the XPD/ERCC2 gene established the patient as heterozygote compound with a novel, N-terminal Y18H mutation and a known C-terminal (TTD) mutation, A725P. The possible interplay between gene products and the patient phenotype is discussed.Entities:
Keywords: Trichothiodystrophy; XPD-gene; novel mutation; overlap syndrome; xeroderma pigmentosum
Year: 2013 PMID: 25002996 PMCID: PMC3916142 DOI: 10.4161/rdis.24932
Source DB: PubMed Journal: Rare Dis ISSN: 2167-5511

Figure 1. Cell cultures and results. Patient's cells were mixed 1:1 with normal control fibroblasts preloaded with cytoplasmic beads. The mixed cultures were assayed for unscheduled DNA synthesis (A) and recovery from transcription inhibition (B). Red fluorescence shows the NER activity, and blue color reflects the DAPI signal. White arrows indicate the 238DOD cells, as recognized by not containing cytoplasmic beads. (C) Mixed cultures as described for panels A/B,immunostained for TFIIH core component XPB (green fluorescence). (D) Measured NER-activity in TTD238DOD and a control cell line. (E) Measured XPB expression in TTD238DOD and a control cell line

Figure 2. Cell survival assay.

Figure 3. ERCC2/XPD sequence analysis of TTD238DOD Relevant parts of peak plots from standard capillary sequencing analysis of TTD238DOD fibroblast DNA. The patient is a compound heterozygote for two mutations. Top: XPD exon 2, bottom XPD exon 22.
Table 1. Clinical findings of TTD238DOD.

Figure 4.(A) TTD238DOD age 8. (B) TTD238DOD age 10. (C) TTD238DOD age 22. (D) TTD238DOD age 28.

Figure 5. Lentiginous and dry skin. (A) Lentiginous back of TTD238DOD. (B) Close-up of (A) with ichthyosiform skin.

Figure 6.(A−D) Nail changes with distal nail splitting and koilonychias.

Figure 7. Eye changes. (A) Retinal degenerative changes. (B) Limbal corneal neovascularization.